Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

NCT02933242 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
399
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

British Columbia Cancer Agency